Written By

Greg Wohl

Licensed Medicare Specialist

Ozempic (semaglutide) was originally approved by the FDA as a treatment for type 2 diabetes. It has since become widely used for weight management, with a separate formulation called Wegovy approved specifically for chronic weight management.

For Medicare beneficiaries, coverage depends critically on the diagnosis. Medicare Part D has historically covered Ozempic for type 2 diabetes, but coverage for weight loss alone has been more restricted.

This guide explains the current state of Medicare coverage for Ozempic and related GLP-1 medications, what they cost under Medicare, and what options are available if your plan does not cover them.

Key Takeaways

Ozempic for type 2 diabetes is generally covered by Medicare Part D: When prescribed for type 2 diabetes management, Ozempic (semaglutide) is typically covered by Medicare Part D plans that include it on their formulary. Coverage and cost vary by plan.
Medicare historically excluded weight loss drugs: Until recently, Medicare was prohibited by law from covering drugs used solely for weight loss. This meant Wegovy was not covered by Medicare Part D even though it contains the same active ingredient as Ozempic.
CMS expanded coverage for cardiovascular risk reduction: In 2024, CMS issued guidance allowing Medicare Part D plans to cover semaglutide (Wegovy) for cardiovascular risk reduction in patients with established cardiovascular disease and obesity. This opened a new coverage pathway for some beneficiaries.
The $2,100 Part D cap limits your maximum annual drug cost: In 2026, the annual out-of-pocket cap for Medicare Part D is $2,100. Even for expensive GLP-1 medications, your total annual drug cost is capped at $2,100 once you reach this threshold.
Not all Part D plans cover Ozempic on their formulary: Even when Medicare allows coverage, individual Part D plans decide which drugs to include and at what tier. Ozempic is often placed on a high tier (Tier 4 or 5), resulting in significant cost-sharing.
Prior authorization is commonly required: Most Part D plans that cover Ozempic require prior authorization, meaning your doctor must document the medical necessity of the drug before the plan will cover it.

When Medicare Part D Covers Ozempic

Medicare Part D coverage for Ozempic depends on two factors: the diagnosis for which it is prescribed, and whether your specific Part D plan includes it on its formulary.

Covered indications:

Type 2 diabetes: Ozempic is FDA-approved for improving blood sugar control in adults with type 2 diabetes. When prescribed for this indication, it is generally eligible for Part D coverage, subject to your plan's formulary and tier placement.
Cardiovascular risk reduction (with obesity): Following 2024 CMS guidance, Medicare Part D plans may now cover semaglutide (Wegovy) for patients with established cardiovascular disease and a BMI of 27 or higher. This is a significant expansion for eligible patients.

Not covered under standard Part D:

Weight loss or obesity management alone (without a cardiovascular disease diagnosis)
Cosmetic weight loss

Formulary placement matters: Even if your diagnosis qualifies, your specific Part D plan must include Ozempic on its formulary. Plans are not required to cover every approved drug. If your plan does not cover Ozempic, you may be able to request a formulary exception, switch plans during AEP, or ask your doctor about covered alternatives.

What Ozempic Costs Under Medicare Part D

Ozempic is an expensive medication with a list price of approximately $935 per month without insurance. Under Medicare Part D, your actual cost depends on your plan's tier placement and where you are in the benefit phases.

Typical Part D cost structure for Ozempic:

Benefit Phase	What You Pay	When It Applies
Deductible phase	Full negotiated price	Until you meet your plan deductible (up to $590 in 2026)
Initial coverage phase	25% of drug cost (coinsurance)	After deductible, until you reach $2,100 OOP
Catastrophic phase	$0	After you reach $2,100 OOP for the year

For a drug costing $935 per month, many beneficiaries reach the $2,100 out-of-pocket cap within the first 2 to 3 months of the year. After that, Ozempic costs $0 for the rest of the year.

The Medicare Prescription Payment Plan (M3P) allows you to spread your drug costs across monthly installments throughout the year. This can help with cash flow even if your total annual cost remains the same.

How to Get Ozempic Covered: Prior Authorization and Formulary Exceptions

Even if your diagnosis qualifies for coverage, most Part D plans require prior authorization for Ozempic. Here is how to navigate the process.

Prior authorization steps:

Your doctor submits a prior authorization request documenting your diagnosis, current A1C or other clinical measures, and why Ozempic is medically necessary
The plan reviews the request, typically within 72 hours (or 24 hours for urgent requests)
If approved, coverage begins; if denied, you have the right to appeal

If your plan does not cover Ozempic: You can request a formulary exception. Your doctor must submit documentation explaining why covered alternatives are not appropriate for your condition. Formulary exceptions are not guaranteed but are worth pursuing with documented medical reasons.

Switching plans during AEP: If your current plan does not cover Ozempic or places it on a high tier, compare plans during the Annual Enrollment Period (October 15 to December 7) using Medicare Plan Finder. Filter by your specific medications to find plans with the lowest total cost.

For help comparing Part D plans that cover your medications, schedule a free consultation with our licensed specialists.

Medicare Coverage for Wegovy and Other GLP-1 Medications

The GLP-1 drug class includes several medications beyond Ozempic. Here is how Medicare coverage applies to the most common ones:

Drug	Brand Name	Primary Indication	Medicare Coverage
Semaglutide (injection)	Ozempic	Type 2 diabetes	Generally covered by Part D for diabetes
Semaglutide (injection)	Wegovy	Chronic weight management	Covered for CV risk reduction with obesity (2024 CMS guidance)
Semaglutide (oral)	Rybelsus	Type 2 diabetes	Generally covered by Part D for diabetes
Tirzepatide (injection)	Mounjaro	Type 2 diabetes	Generally covered by Part D for diabetes
Tirzepatide (injection)	Zepbound	Chronic weight management	Limited; may qualify under CV risk reduction guidance

Coverage rules for weight management GLP-1s are evolving. Proposed federal legislation has sought to expand Medicare coverage for obesity drugs more broadly. As of 2026, coverage remains tied to specific medical indications.

What to Do If Medicare Does Not Cover Your GLP-1 Medication

If your Part D plan does not cover Ozempic or Wegovy for your situation, you have several options worth exploring.

Manufacturer savings programs: Novo Nordisk offers patient assistance programs for eligible patients, but these typically exclude Medicare beneficiaries. Check the manufacturer's website for current eligibility rules.
Switch to a covered alternative: Ask your doctor if a covered GLP-1 or other diabetes medication would be appropriate. Metformin, SGLT-2 inhibitors, and other diabetes drugs are generally well-covered by Part D.
Request a formulary exception: If you have tried covered alternatives and they were not effective or caused side effects, your doctor can document this and request an exception to cover Ozempic.
Compare plans during AEP: Use Medicare Plan Finder to find Part D plans that cover your specific medication at the lowest tier. Even a one-tier difference can save hundreds of dollars per year.
Extra Help (Low Income Subsidy): If you qualify for Extra Help, your drug costs are significantly reduced regardless of tier placement. See our guide to reducing Medicare costs based on income for eligibility information.

Medicare and Ozempic: What You Need to Know

Here is a quick summary of the key points:

Ozempic for type 2 diabetes is generally covered by Medicare Part D plans that include it on their formulary
Wegovy for weight loss alone has historically not been covered, but CMS now allows coverage for patients with cardiovascular disease and obesity
Prior authorization is almost always required and your doctor must document medical necessity
The $2,100 Part D OOP cap in 2026 limits your maximum annual drug cost, which helps for expensive GLP-1 medications
If your plan does not cover it, request a formulary exception, compare plans during AEP, or ask your doctor about covered alternatives

Our licensed specialists can review your current Part D plan and help you find the best coverage for your medications. Schedule a free consultation for a personalized plan comparison.